Yi Zuo to Humans
This is a "connection" page, showing publications Yi Zuo has written about Humans.
Connection Strength
0.224
-
Li G, Xu X, Sun B, Zuo YY. Biophysical mechanisms of SARS-CoV-2-induced surfactant inhibition. Biophys J. 2025 Nov 04; 124(21):3733-3741.
Score: 0.043
-
Zuo YY. Comparative biophysical study of clinical surfactants using constrained drop surfactometry. Am J Physiol Lung Cell Mol Physiol. 2024 Oct 01; 327(4):L535-L546.
Score: 0.040
-
Xu X, Li G, Zuo YY. Effect of Model Tear Film Lipid Layer on Water Evaporation. Invest Ophthalmol Vis Sci. 2023 01 03; 64(1):13.
Score: 0.036
-
Xu X, Li G, Sun B, Zuo YY. S2 Subunit of SARS-CoV-2 Spike Protein Induces Domain Fusion in Natural Pulmonary Surfactant Monolayers. J Phys Chem Lett. 2022 Sep 08; 13(35):8359-8364.
Score: 0.035
-
Ju JTJ, Boisvert LN, Zuo YY. Face masks against COVID-19: Standards, efficacy, testing and decontamination methods. Adv Colloid Interface Sci. 2021 Jun; 292:102435.
Score: 0.032
-
Fan Q, Wang YE, Zhao X, Loo JS, Zuo YY. Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant. ACS Nano. 2011 Aug 23; 5(8):6410-6.
Score: 0.016
-
Zhang H, Fan Q, Wang YE, Neal CR, Zuo YY. Comparative study of clinical pulmonary surfactants using atomic force microscopy. Biochim Biophys Acta. 2011 Jul; 1808(7):1832-42.
Score: 0.016
-
Chen Y, Yang Y, Xu B, Wang S, Li B, Ma J, Gao J, Zuo YY, Liu S. Mesoporous carbon nanomaterials induced pulmonary surfactant inhibition, cytotoxicity, inflammation and lung fibrosis. J Environ Sci (China). 2017 Dec; 62:100-114.
Score: 0.006